Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boasson

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|July 1, 1978
[Evolution of patients with rheumatoid arthritis treated with immunosuppressive agents between 1965 and 1973]J C Renier, C Bregeon, C Bonnette, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple MyelomaJ L Harousseau, M Attal, M Divine, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1994
[Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia]G Andreu, M Benbunan, M Boasson, et al.
Bone Marrow Transplantation|June 1, 1995
Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Blood|June 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patientsP Colonna, J P Jais, B Desablens, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires|July 1, 1978
[Evolution of patients with rheumatoid arthritis treated with immunosuppressive agents between 1965 and 1973]J C Renier, C Bregeon, C Bonnette, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple MyelomaJ L Harousseau, M Attal, M Divine, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1994
[Utilization of transfusions in the hematology clinic. Recommendations of the Evaluation Commission of the French College of Hematologists for transfusion support in the treatment of acute leukemia in therapeutic aplasia]G Andreu, M Benbunan, M Boasson, et al.
Bone Marrow Transplantation|June 1, 1995
Comparison of autologous bone marrow transplantation and peripheral blood stem cell transplantation after first remission induction treatment in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Blood|June 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1996
Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patientsP Colonna, J P Jais, B Desablens, et al.
Pageof 6